A tube with no visible debris tells you almost nothing. That is the whole problem with the draft row. Someone holds a clarified eluate to the light, sees a clean liquid, writes recovered, and the record stays wrong for months. Verification is the entire game here – the same rule that separates a real operation from the best casinos not on gamstop, where the audit trail is the only thing worth reading. The proposed F2 fails that test in five places.
What the draft row gets wrong
Teaching-panel elution cannot be transplanted into a BSL-4 field method: different buffer, different containment, different validation. “Visibly clear” is a debris criterion, not an infectivity one. A pre-culture screen – particularly RNA – proves neither infectious virus nor its absence, so it can inform but never decide. Vero E6 is broadly permissive, which makes it a substrate, not a selectivity check, and pooled M with mixed field background needs a matrix control and a dilution series rather than a relabeled tube. And recovered entered at transfer is simply false; at that moment the culture is inoculated, nothing more.
F2, corrected bench entries
- Receipt and accession. Check ID, class (S or M), chain of custody, container integrity, cold-chain log, and volume. For M, confirm the pool record names the number and site type of swabs already pooled. Pass: all match and M pool record complete. Fail: quarantine, do not culture, notify supervisor, log deviation. Record: accession, class, pool composition, cold-chain temperature.
- Holdback and screen. Remove 0.2 mL of eluate before any dilution and store per BSL-4 SOP. Enter the approved screen result without letting it gate culture. Pass: holdback labeled, ≥1.5 mL remains. Fail: reprocess from retained eluate; if none, request a new specimen. Record: holdback ID, screen method and result, remaining volume.
- S elution and clarification. Place the S swab in 2 mL viral transport medium (DMEM high glucose, 2% FBS, 10 mM HEPES, 1% pen-strep, 0.5 µg/mL amphotericin B). Vortex 30 s, hold 15 min at room temperature, centrifuge 3,000 × g for 10 min at 4°C, then filter the supernatant through 0.45 µm. Material going forward: the clarified filtrate only – swab and pellet are discarded. Pass: ≥1.5 mL filtrate, no visible particulate. Fail: re-centrifuge with a fresh filter; if it clogs twice, take a new aliquot and log it. Record: volumes, g-force, filter lot.
- M split – the required divergence. M is processed as above but is not carried forward as a single neat tube. Prepare M-neat, M 1:10, and M 1:100, and in parallel run a matched matrix control built from negative field swabs of the same site type, processed identically. Pass: three M dilutions plus matrix control, all linked to the M pool ID. Fail: no matrix control means M is not evaluable – do not inoculate, request a new M, record invalidation. Record: pool ID, dilution series, matrix-control ID.
- Substrate preparation. Seed Vero E6 (ATCC CRL-1586) in 24-well plates with 12 mm coverslips in DMEM high glucose + 10% FBS + 1% pen-strep. Pass: 80-90% confluent, no contamination, two wells per condition. Fail: discard the plate and prepare a new one. Record: cell line, passage, plate ID, confluence, incubator settings.
- Inoculation. Apply 0.2 mL per well to duplicate wells, adsorb 60 min at 37°C, 5% CO₂, rocking every 15 min. Remove inoculum, add 1 mL maintenance medium (DMEM + 2% FBS + 1% pen-strep). Include cell-only and medium-only wells. Pass: correct well map, no cross-well spill, controls present. Fail: spill or contamination voids the run; repeat with fresh wells and log it. Record: specimen ID, dilution, well map, adsorption time, medium, controls.
- First primary-culture check, day 3-4. Examine by inverted microscopy. Pass: monolayer intact, no bacterial or fungal growth, matrix control shows no cytotoxicity at the dilution used. Fail: contaminated or cytotoxic wells are discarded; the corresponding dilution is not interpreted and is repeated at the next lower dilution. Record: check date, magnification, per-well observation, matrix-control result.
S versus M at this handoff
| Step | S | M (already pooled) |
|---|---|---|
| Going forward | Clarified filtrate, neat and 1:10 | Clarified filtrate, 1:10 and 1:100 only if matrix control permits |
| Required control | Cell-only and medium-only | Matched matrix-control composite, processed identically |
| Attribution | Single source | Composite only; no individual-source claim |
| Status at transfer | Inoculated | Inoculated |
First-check acceptance criteria
- Monolayer intact with no bacterial or fungal contamination.
- No cytotoxicity in the matrix control at the dilution being read.
- Any CPE recorded as an observation, not an interpretation; harvest 0.2 mL for passage and retain the remainder.
- No well reported as positive on the basis of a pre-culture screen alone.
## 3. Status and remaining evidence
**Status earned at this handoff: inoculated – primary culture initiated.** Not recovered, not isolated.
Before the record can read *recovered isolate*, the file still needs: reproducible CPE on passage with a retained passage stock; HTNV identity confirmed by RT-PCR and sequencing or by immunofluorescence with a validated monoclonal panel; a clonal plaque-purified line; documented BSL-4 containment for every manipulation; and a completed worksheet linking specimen, matrix control, passage history, and identity result. Until those exist, the isolate-status field stays at inoculated.